ecrin-mdr-crcClinical2004Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2199452Bulgaria10CapecitabineECRIN MDRCompletedfalseA Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal CancerThis study will evaluate the efficacy, safety, and pharmacoeconomics of oral capecitabine in patients with metastatic colorectal cancer. The anticipated time on study treatment is 3-12 months, and the target sample size is 28 individuals.2004-10-152199452NCT02567331